Design
Review
Authors
Loading...
May guide post-eradication IPV strategies in low-resource settings; leaves open feasibility of target pricing.
Highlights strategies to develop affordable inactivated poliovirus vaccines for developing countries to mitigate risks associated with oral poliovirus vaccines post-eradication.
Okayasu et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: